M, M., M, M., RP, A., AV, B., A, C., M, L., . . . Z, Z. (2022). Lead Optimization to Advance Protease-Activated Receptor-1 Antagonists in Early Discovery. Journal of medicinal chemistry, 65(7), 5575. https://doi.org/10.1021/acs.jmedchem.1c02048
Chicago Style (17th ed.) CitationM, Mandal, et al. "Lead Optimization to Advance Protease-Activated Receptor-1 Antagonists in Early Discovery." Journal of Medicinal Chemistry 65, no. 7 (2022): 5575. https://doi.org/10.1021/acs.jmedchem.1c02048.
MLA (9th ed.) CitationM, Mandal, et al. "Lead Optimization to Advance Protease-Activated Receptor-1 Antagonists in Early Discovery." Journal of Medicinal Chemistry, vol. 65, no. 7, 2022, p. 5575, https://doi.org/10.1021/acs.jmedchem.1c02048.
Warning: These citations may not always be 100% accurate.